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Abstract 
Purpose: Resistance exercise (RE) can improve many cardiovascular disease (CVD) risk factors, but 
specific data on the effects on CVD events and mortality are lacking. We investigated the associations of 
RE with CVD and all-cause mortality and further examined the mediation effect of body mass index (BMI) 
between RE and CVD outcomes. 
Methods: We included 12,591 participants (mean age, 47 yr) who received at least two clinical 
examinations 1987-2006. RE was assessed by a self-reported medical history questionnaire. 
Results: During a mean follow-up of 5.4 and 10.5 yr, 205 total CVD events (morbidity and mortality 
combined) and 276 all-cause deaths occurred, respectively. Compared with no RE, weekly RE frequencies 
of one, two, three times or total amount of 1-59 min were associated with approximately 40%-70% 
decreased risk of total CVD events, independent of aerobic exercise (AE) (all P values <0.05). However, 
there was no significant risk reduction for higher weekly RE of more than four times or ≥60 min. Similar 
results were observed for CVD morbidity and all-cause mortality. In the stratified analyses by AE, weekly 
RE of one time or 1-59 min was associated with lower risks of total CVD events and CVD morbidity 
regardless of meeting the AE guidelines. Our mediation analysis showed that RE was associated with the 
risk of total CVD events in two ways: RE had a direct U-shaped association with CVD risk (P value for 
quadratic trend <0.001) and RE indirectly lowered CVD risk by decreasing BMI. 
Conclusion: Even one time or less than 1 h·wk of RE, independent of AE, is associated with reduced risks 
of CVD and all-cause mortality. BMI mediates the association of RE with total CVD events. 
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Abstract
Purpose—Resistance exercise (RE) can improve many cardiovascular disease (CVD) risk 
factors, but specific data on the effects on CVD events and mortality are lacking. We investigated 
the associations of RE with CVD and all-cause mortality, and further examined the mediation 
effect of body mass index between RE and CVD outcomes.
Methods—We included 12,591 participants (mean age 47 years) who received at least two 
clinical examinations 1987–2006. RE was assessed by a self-reported medical history 
questionnaire.
Results—During a mean follow-up of 5.4 and 10.5 years, 205 total CVD events (morbidity and 
mortality combined) and 276 all-cause deaths occurred, respectively. Compared with no RE, 
weekly RE frequencies of one, two, three times or total amount of 1–59 minutes were associated 
with approximately 40–70% decreased risk of total CVD events, independent of aerobic exercise 
(AE) (all p-values <0.05). However, there was no significant risk reduction for higher weekly RE 
of more than four times or ≥60 minutes. Similar results were observed for CVD morbidity and all-
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cause mortality. In the stratified analyses by AE, weekly RE of one time or 1–59 minutes was 
associated with lower risks of total CVD events and CVD morbidity regardless of meeting the AE 
guidelines. Our mediation analysis showed that RE was associated with the risk of total CVD 
events in two ways: RE had a direct U-shape association with CVD risk (p-value for quadratic 
trend <0.001) and RE indirectly lowered CVD risk by decreasing BMI.
Conclusion—Even one time or less than one hour/week of RE, independent of AE, is associated 
with reduced risks of CVD and all-cause mortality. BMI mediates the association of RE with total 
CVD events.
Keywords
resistance exercise; cardiovascular disease; mortality; body mass index; mediation analysis; 
aerobic exercise
Introduction
Cardiovascular disease (CVD) such as heart attack or stroke is the leading cause of death, 
particularly in most developed countries (1). Therefore, continuous efforts are needed to 
reduce CVD risk. The health benefits of physical activity (PA), primarily aerobic exercise 
(AE), have been well-documented from the perspective of CVD and premature mortality (2–
4). However, most studies on resistance exercise (RE) have focused on bone health, physical 
function, and quality of life in older adults, or metabolic health outcomes such as type 2 
diabetes (5–8). There is still limited research directly examining the association of RE with 
the risk of CVD and mortality, and studies have reported inconsistent results (9–11). Several 
studies have suggested favorable effects of muscular strength, as a proxy indicator of RE, on 
cardiovascular health and mortality (12–15, 16). However, these results can not directly 
inform recommendations on practical exercise. Thus, further evidence is warranted to reveal 
the association of RE and cardiovascular health and mortality independent of AE, as well as 
to inform recommendations on RE.
Obesity commonly classified using body mass index (BMI) is among the mediators in the 
mechanisms linking PA, focusing on AE, to cardiovascular health (17). Some individuals 
even including medical professionals believe that the cardiovascular benefits of exercise may 
be mostly from weight loss. Furthermore, to our knowledge, there is very limited study 
investigating the mechanism underlying the association of RE, independent of AE, with 
cardiovascular health. Investigating the potential mediation effect of BMI on the association 
between RE and CVD adjusting for other CVD risk factors provides us with important data 
on RE related CVD preventive strategies.
Our study aimed to investigate the associations of RE, independent of AE, with the risk of 
total CVD events (morbidity and mortality combined), CVD morbidity, and all-cause 
mortality in a large prospective cohort of adult men and women. Based on the hypothesis of 
the pairwise causal relationship of RE and BMI with CVD risk, we further examined the 
mediation effect of BMI on the associations of RE with total CVD events, CVD morbidity, 
and all-cause mortality through a joint modeling approach.
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The Aerobics Center Longitudinal Study (ACLS) is a cohort study of individuals who 
received periodic preventive medical examinations at the Cooper Clinic in Dallas, Texas. 
The participants were volunteers sent by their employers, physicians, or were self-referred. 
They came to the Cooper Clinic periodically for preventive health examinations and for 
counseling on lifestyle habits including exercise, nutrition, stress management, etc. The 
participants are primarily non-Hispanic white (> 95%), well-educated (80% college 
graduates), and from middle to upper socioeconomic strata (18). In the present study, we 
included participants who received at least two clinical examinations between 1987 and 
2006. Among 13,722 individuals, 1,131 participants were excluded due to reported 
myocardial infarction, stroke, or cancer at baseline. Our final sample included 12,591 
participants (21% women) aged 18 to 89 years (mean age 47) at baseline. The study was 
annually reviewed and approved by the Cooper Institute institutional review board. Written 
informed consents were obtained from all participants for baseline and follow-up 
examinations.
Clinical Examination.
All participants received comprehensive medical examinations at baseline and follow-up 
visits after an overnight fast of at least 12 hours. Body mass index was calculated as weight 
in kilograms divided by height in meters squared. Resting blood pressure was measured 
according to standard procedures with a mercury sphygmomanometer. Serum samples were 
analyzed for glucose and total cholesterol using standardized bioassays. The assessment of 
hypertension, diabetes, and hypercholesterolemia were based on a history of physician 
diagnosis or measured phenotypes that met clinical thresholds for each condition. Age, sex, 
smoking status, alcohol consumption, parental history of CVD, and PA were assessed by a 
self-reported medical history questionnaire. Participants were classified as non-smokers or 
current smokers. Heavy alcohol drinker was defined as >14 alcohol drinks per week for men 
and more than seven for women (19). In the medical questionnaire, leisure-time aerobic and 
resistance exercises during the past three months were assessed as part of the medical 
examination. Aerobic exercise was categorized as meeting the recommended guidelines 
(≥500 metabolic equivalent [MET]-minutes per week, which was equivalent to 150 minutes 
of moderate or 75 minutes of vigorous weekly AE) or not, according to the United States 
(U.S) Department of Health and Human Services (DHHS) PA Guidelines (2).
Assessment of Resistance Exercise History.
Resistance exercise using either free weights or weight training machines was evaluated by 
weekly frequency (times/week) and average exercise time (minutes) for each session. The 
total weekly amount of RE was calculated by multiplying weekly frequency with the 
average minutes per session. Participants were classified into five categories by RE 
frequency of zero, one, two, three, and four or greater≥ times/week and four categories by 
total RE amount of 0, 1–59, 60–119, and ≥120 minutes/week for the main analyses. PA 
questionnaire including both resistance and aerobic exercise is available in an earlier study 
(20).
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Assessment of End Points.
In this study, CVD morbidity was defined as an incidence of myocardial infarction or stroke, 
and was assessed at baseline and each follow-up examination. Mortality through December 
31, 2003 was ascertained by the National Death Index. Death from CVD was identified by 
the International Classification of Diseases, Ninth Revision codes 390–449.9 and Tenth 
Revision codes I00-I78. The primary outcomes were total CVD events (development of 
CVD morbidity or death from CVD), development of CVD morbidity, and all-cause 
mortality. In the corresponding longitudinal analysis, we included all the records from 
baseline to the end points for the participants with event, or from baseline to the last 
examination through 2006 for the participants who survived (did not develop the event). In 
Cox regression models, the follow-up years (survival time) of participants with event were 
calculated from baseline to the end points. For the ones who survived, follow-up years were 
counted from baseline to the last examination for CVD morbidity, and for CVD and all-
cause mortality, from baseline to the end year of 2003 (since mortality data is available until 
2003) or the last examination through 2006, which came later.
Statistical Analysis.
We described baseline characteristics of participants by their weekly frequency and amount 
of RE.
A series of Cox proportional hazard models were fitted to assess the effect of weekly RE 
frequency (times/week) and total amount (minutes/week) on total CVD events, CVD 
morbidity, and all-cause mortality. Like all human activities, weekly RE and AE levels 
(represented by frequency or total amount) naturally vary over time. Such variations, broadly 
termed as measurement errors in the statistics literature (21), are known to cause estimation 
biases and reduced statistical power. Since the baseline RE and AE levels were subject to 
such measurement error, we instead used the long term RE and AE levels, measured by 
average frequency or average minutes/week during the follow-ups (e.g., average 3.7 times of 
RE measurement during 5.3 years of follow-up in total CVD events), as covariates in the 
Cox models. Using the average of repeated measurements as the covariate is a simple 
practice of regression calibration (21) and was used in a similar study (22). We classified 
participants according to average RE frequency and total amount in Cox models, therefore 
the number of participants in corresponding categories for CVD outcomes and all-cause 
mortality were slightly different. We fitted the following two sets Cox models to examine the 
associations of RE frequency and total amount with CVD events and all-cause mortality 
adjusting for different confounders: in model 1, the results were adjusted for baseline 
examination year, age, and sex; in model 2, we further adjusted for baseline smoking status, 
heavy alcohol drinking, BMI, parental history of CVD, meeting the AE guidelines, 
hypertension, diabetes, and hypercholesterolemia. To assess the effect of RE independent of 
AE, we further conducted stratified analysis by meeting AE guideline or not. Interactions 
between AE and RE categories were also tested by comparing the Cox models containing 
both main effects and interaction terms with models containing main effects only using 
likelihood ratio test.
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To investigate the association between RE and BMI, we applied a linear mixed effect model, 
which was a standard model in longitudinal data analysis taking into account the follow-up 
observations. We then examined the mediation relationship among RE, BMI, and the 
outcomes following the standard procedures of mediation analysis proposed by Baron and 
Kenny (23). With total CVD events as an example, we presented causal relationships 
between RE and BMI, BMI and the risk of total CVD events, and RE and the risk of total 
CVD events (Figure 1). In the first step of mediation analysis, we ran a series of Cox models 
to examine the association of RE with total CVD events, with adjustment for all potential 
confounders excluding BMI. In the second step, we assessed the longitudinal association 
between RE and BMI with a linear mixed effect model. To model the variation in baseline 
BMI levels and temporal trend, we included subject-specific intercepts and slopes as random 
effects, while controlling the fixed effects of examination year, baseline age, sex, current 
smoking, heavy alcohol drinking, and meeting the AE guidelines. In the final step, we 
applied a joint model of longitudinal and survival data (24, 25) in which the longitudinal 
observation of BMI was modeled through a linear mixed effect model, the risk of total CVD 
events was fitted by a Cox proportional hazard model, and the association of these two 
models lied in that BMI was simultaneously a covariate for the Cox model. Since joint 
modeling is a relatively new approach in epidemiological research, we provide here more 
detailed explanations and methods to help readers, including future investigators, understand 
it clearly. The hazard function of total CVD events was modeled as:
ℎi t Mi t , REi, Xi = ℎ0 t exp γ1REi + γ2REi2 + γ3TXi + αMi t , [1]
where Mi(t) denoted the true value of BMI of the i-th subject at time t, Xi represented 
confounding variables including baseline examination year, age, sex, current smoking, heavy 
alcohol drinking, parental history of CVD, meeting the AE guidelines, hypertension, 
diabetes and hypercholesterolemia, and h0(t) was a baseline risk function. Parameter α 
indicated the effect of the underlying true BMI on the risk of total CVD events, while γ1 and 
γ2 quantified the direct effect of RE on total CVD events. The longitudinal model for 
observations of BMI was as follows:
BMIi t = Mi t + εi t ,
Mi t = β0 + b0i + β1 + b1i t + β2 REi t + β3TZi t ,
[2]
where the error item εi ∼ N 0, σ2 , and the random intercept b0i and random slope b1i were 
assumed to follow a joint normal distribution with mean 0, Zi represented covariates 
including examination year, baseline age, sex, current smoking, heavy alcohol drinking and 
meeting the AE guidelines. Since β2 represented the effect of RE on BMI, αβ2 represented 
an indirect effect of RE on the risk of total CVD events through the Cox model. We fitted 
this model with a Bayesian approach. The baseline hazard function in Cox model was 
estimated by penalized spline, and independent univariate diffuse normal priors were 
assumed for fixed effect parameters in the longitudinal model, and parameters in the Cox 
model (26). Mediation analyses were also conducted for CVD morbidity and all-cause 
mortality in the same way.
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Based on no significant interactions by sex on the associations between RE and the 
outcomes using interaction terms in the regression and by comparing risk estimates in the 
sex-stratified analyses, pooled analyses including both men and women were performed. 
Also, the proportional hazard assumptions were confirmed by Schoenfeld tests (27). All 
statistical analyses were conducted using R version 3.3.2. R package “JMbayes” was applied 
for joint modeling analysis and 2-sided p-values <0.05 were deemed significant.
Results
Among 12,591 participants, 205 total CVD events, 127 CVD morbidity (nonfatal CVD 
events), and 276 all-cause deaths occurred during an average follow-up of 5.4, 5.3 and 10.5 
years. Table 1 shows baseline characteristics of participants according to their frequency of 
RE (supplemental Table S1 shows baseline characteristics by amount of RE). At baseline, 
3,438 individuals (27%) engaged in some RE in this population. Compared with non-
participants of RE, the participants of RE tend to be male, younger, non-smokers, more 
aerobically active, and with lower BMI. They also had a lower rate of hypertension, 
diabetes, hypercholesterolemia, and history of parental CVD.
Compared with no RE, hazard ratios (HRs) (95% confidence intervals [CIs]) of total CVD 
events across weekly RE frequencies of one, two, three, and four or greater times were 0.26 
(0.16 to 0.42), 0.41 (0.27 to 0.63), 0.52 (0.31 to 0.86), and 1.17 (0.67 to 2.04), respectively, 
after adjusting for examination year, age, and sex in Model 1 (Table 2). The HRs (95% CIs) 
of total CVD events across weekly total RE amount of 1–59, 60–119, and ≥120 minutes 
were 0.33 (0.23–0.47), 0.57 (0.36–0.91), and 0.81 (0.46–1.44), respectively, in the same 
Model 1. These associations were slightly attenuated, but mostly remained significant after 
additional adjustment for potential confounders including meeting the AE guidelines and 
health conditions in the full Model 2. When assessed as a continuous variable, weekly RE 
frequency had a U-shape association with total CVD events (p-value for quadratic trend 
<0.001), which reached the lowest HR (95% CI) of 0.51 (0.35 to 0.68) at about two times/
week (Figure 2(a)). We observed similar trend for the total amount of weekly RE, with the 
lowest HR at 1.5 hours/week (Figure 2 (b)) although not significant. For CVD morbidity, we 
observed reduced risk of adverse events for RE frequency of one, two times/week and total 
amount of 1–59 minutes/week compared with no RE, after adjusting for all potential 
confounders. For all-cause mortality, decreased risk was observed for RE frequency of one 
times/week and total amount of 1–59 minutes/week. In the dose-response analysis, the 
association of RE frequency with both CVD morbidity and all-cause mortality showed a U-
shape curve, with the lowest risk achieved at RE frequency of two times/week (Figure 2 (c) 
and (e)). However, quadratic trends for the associations of total RE amount with CVD 
morbidity and all-cause mortality were not significant (p-values were 0.21 and 0.75 
respectively). When we used the baseline values of RE frequency and amount in further 
sensitivity analyses, we did not observe significant results after adjusting for all potential 
confounders (data not shown). Therefore, it is possible that the risks of CVD and all-cause 
mortality were associated with long-term RE, rather than one time baseline value of RE, 
which has significant measurement errors because people in general over-report their 
physical activity. When we excluded those early cases of CVD events and all-cause 
mortality within the first two years of follow-up to reduce potential subclinical conditions on 
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the associations of RE with outcomes and minimize possible reverse causation, we found 
similar results (data not shown).
To assess the effects of RE on the risks of CVD and all-cause mortality independent of AE, 
stratified analyses were conducted by meeting the recommended AE guidelines or not 
(supplemental Table S2). Compared with no RE, RE frequency of one time/week and the 
total amount of 1–59 minutes/week were associated with 75% (HR: 0.25, 95% CI: 0.14 to 
0.46) and 60% (HR: 0.40, 95% CI: 0.21 to 0.52) lower risk of total CVD events, 
respectively, among the ones meeting AE guidelines, and 65% (HR: 0.35, 95% CI: 0.16 to 
0.77) and 59% (HR: 0.41, 95% CI: 0.23 to 0.74) lower risk of total CVD events, 
respectively, among those not meeting AE guidelines. We also observed similar results for 
CVD morbidity with significantly reduced risks in one time/week of RE frequency and the 
total amount of 1–59 minutes/week of RE regardless of meeting AE guidelines.. Compared 
with no RE, engaging in RE of one, two, or three times/week and 1–59 minutes/week was 
associated with decreased risk of all-cause mortality among participants meeting 
recommended AE. However, we did not observe significant all-cause mortality risk 
reduction with doing RE in the group of not meeting AE guidelines. These stratified 
analyses suggest that one could get CVD benefits from RE whether they meet the AE 
guidelines or not. However, all-cause mortality benefits from RE is only obtained when they 
meet the recommended AE (p-values for the interaction between RE and AE for all-cause 
mortality were 0.06 and 0.04 for RE frequency and amount, respectively).
Before testing the mediation effect of BMI between RE and CVD, we investigated the 
longitudinal association of RE with BMI in additional analyses. When taken as continuous 
variable, weekly frequency and total amount of RE were significantly associated with BMI 
after adjusting for all potential confounders including AE (p-value <0.001). Participants who 
did any RE would have a 0.13 (SE: 0.017) kg/m2 lower level of BMI compared with the 
ones with no RE. We then examined the mediation associations among RE, BMI, and total 
CVD events, CVD morbidity, and all-cause mortality by a joint modeling approach (Table 
3). For the risk of total CVD events, in the longitudinal model, weekly frequency of RE was 
inversely associated with BMI (coefficient: −0.04; 95% CI: −0.05 to −0.03 in each RE 
frequency); in the Cox model, higher BMI was associated with a higher risk of total CVD 
events (HR: 1.06; 95% CI: 1.02 to 1.10 in each BMI unit), and RE frequency had a U-shape 
association with the risk of total CVD events (p-value for quadratic trend <0.001 between 
each RE frequency and total CVD events). Based on this joint modeling result, we found 
that RE frequency was associated with the reduced risk of total CVD events in two ways: RE 
had a U-shape association with the risk of total CVD events. On the other hand, RE also 
lowered the risk of total CVD events through decreasing BMI, which is depicted in Figure 1. 
However, the mediation effects of BMI were relatively weaker on the associations of RE 
frequency with CVD morbidity (HR: 1.04; 95% CI: 0.99–1.09) and all-cause mortality (HR: 
1.03; 95% CI: 0.996–1.07). For the total amount of RE (weekly hours), we did not observe 
significant associations between weekly hours of RE and three outcomes in Cox model part. 
The inverse association between RE hours and BMI in the longitudinal model, combining 
with the significant effect of BMI on risk of total CVD event and all-cause mortality in Cox 
model, implies that RE hours lowers the risk of total CVD event and all-cause mortality 
indirectly through BMI.
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In this study, we found that RE, especially low-to-moderate frequency (one-three times/
week) or even <one hour/week, was associated with lower risks of total CVD events, 
independent of AE, compared with no RE, in a large cohort of men and women (mean age: 
46.5 years, range: 18–96). In addition, higher RE frequency of ≥four times/week and amount 
of ≥120 minutes/week did not show significant cardiovascular benefits. These results are 
consistent with the findings of the U-shaped associations between RE and CVD events from 
the dose-response analyses using the continuous variables of weekly RE frequency and 
amount (Figure 2 (a) and (b)). For the associations of RE with CVD morbidity and all-cause 
mortality, the results of the dose-response analyses were similar although less strong. 
Previous studies have shown mixed results regarding the association between RE and CVD 
risk. In the Women’s Health Study, Kamada et al. (22) also found that strength training for 
1–59 minutes/week was associated with lower risk of CVD mortality (including death from 
myocardial infarction, stroke, angioplasty, and coronary artery bypass grafting), compared 
with no strength training, for a cohort of middle aged and older women. They also observed 
significant quadratic associations between amount of weekly RE with CVD mortality and 
all-cause mortality. For the same study, another research showed that strength training for 
60–120 minutes/week was associated with significant risk reduction of CVD events, and no 
further significant benefits was observed for strength training of >120 minutes/week (9). 
Although not tested statistically, the results implied the quadratic association as similar with 
the current findings. In this study, they also observed a 17% risk reduction for CVD events 
among women engaging in strength training, compared with the ones who reported no 
strength training. In our study, the corresponding reduction of risk was 55% (HR: 0.45; 95% 
CI: 0.33 to 0.61). The possible explanations of the higher total CVD risk reduction in our 
study would be related to the facts that our study includes both men and women who are 
also younger (mean age: 46.5 years, range: 18–96) than the participants in the Women’s 
Health Study (mean age: 62.6 years, range: 47–98). It is noteworthy that results in the last 
research were not adjusted for CVD risk factors including hypertension, diabetes and 
hypercholesterolemia. In a cohort of middle aged and older men from the Health 
Professionals’ Follow-Up Study, Tanasescu et al.(10) found that weight training for at least 
30 minutes per week was associated with a 23% risk reduction of coronary heart disease 
compared with no weight training after adjusting for potential confounders excluding 
baseline diabetes, high cholesterol levels, and hypertension. However, in another report from 
the same study with higher amounts of weight training categories, they found an U-shaped 
association between weight training and total CVD events (fatal and nonfatal myocardial 
infarction and stroke) with significant benefits below 120 minutes/week, but no further 
benefits in ≥120 minutes/week of weight training (11).
There has been compelling evidence that RE prevents decline in skeletal muscle mass (28), 
and long-term participation in RE increases energy expenditure (29, 30), and relieves 
anxiety, depression, and insomnia in clinical depression (31). It was also shown that RE had 
beneficial effects on cardiovascular risk factors including obesity, diabetes, hypertension, 
hypercholesterolemia, and decreased physical function (5–8, 32–36). We observed a 
significant U-shaped association between RE and CVD risk after adjusting for BMI, 
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diabetes mellitus, hypertension and hypercholesterolemia. Possible explanations for the 
CVD benefits from low-to-moderate RE might include improved physical function, 
increased energy expenditure, and emotional factors as mentioned above. Although there is 
no clear understanding why there is no further cardiovascular benefits in the higher amounts 
of RE, a meta-analysis suggested that high intensity RE may increase arterial stiffness 
leading to subsequent CVD events (37). A significant pressure load is imposed on the heart 
during RE, and heavy RE may lead to a mild form of cardiac hypertrophy (38). In addition, a 
marked rise in blood pressure is secondary to RE, thus high level of RE may have adverse 
effect on those with uncontrolled hypertension (6, 39). Another possible explanation of no 
further cardiovascular benefits in the higher amounts of RE would be that the room for 
benefits could be much smaller for those participants in the higher amounts of RE (≥four 
times/week) in which 85% of them met the AE guidelines compared with those doing one 
time/week of RE in which 72% of them met the AE guidelines. However, further 
investigations are clearly needed on this controversial issue of the dose-response relationship 
between RE and CVD risk.
We also confirmed that BMI was a mediator in the relationship of RE with total CVD 
events. Several studies in the literature took BMI into account as a potential mediator in the 
relationship of PA and CVD risk. Erez et al. (40) indicated that BMI was among the CVD 
risk factors affecting the association of cardiorespiratory fitness and CVD morbidity. The 
Women’s Health Study reported that BMI contributed 10% of the observed inverse 
association between PA and risk of CVD events (17). The previous research mostly focused 
on associations between baseline cardiorespiratory fitness (baseline PA), baseline 
observations of CVD risk factors, and subsequent CVD outcomes (17, 40, 41). Mora et al. 
showed no significant association existed between baseline PA and risk of CVD after 
adjusting for baseline levels of known risk factors. However, Kamada et al. (22) revealed a 
quadratic association between cumulative-averaged amount of strength training and 
mortality of CVD after adjusting for baseline CVD risk factors. In the current study, we 
considered the associations between long-term RE, longitudinal observation of BMI, and 
risk of CVD events in mediation analysis, and the result showed that weekly RE frequency 
had a U-shape relationship with risk of CVD events (lowest risk attained at two times/week, 
not shown) after adjusting for AE, longitudinal observation of BMI, and other potential 
confounders. The result implies that one would get CVD benefits from RE regardless of the 
long-term levels of BMI. On the other hand, the result seems more convincible including the 
baseline as well as the dynamic information of variables into mediation analysis.
Strengths of this study include the large sample size across a wide age-range, extensive CVD 
morbidity and mortality follow-up, and repeated measures of exposures. In addition, we 
proposed the application of a joint modeling approach in mediation analysis to more 
rigorously investigate the effect of BMI on the association between RE and the risks of CVD 
as well as all-cause mortality.
Study Limitations.
There are several limitations in this study. We used self-reported AE and RE in the current 
study, and people tend to over-report their leisure-time exercise, especially RE possibly more 
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in men (e.g., a competitive, bragging culture in weight lifting). Therefore, this 
overestimation of self-reported RE may have induced possible underestimation of the true 
health effects of RE on BMI, CVD, and mortality outcomes. For example, the possible 
explanation of the weaker associations between the total amount of RE (total weekly hours) 
and all three outcomes may be related to the additive over-reporting of RE because total 
weekly hours of RE were calculated by multiplying self-reported weekly frequency of RE 
with self-reported average exercise time (minutes) per session. However, to our knowledge, 
this is the first comprehensive study investigating the independent associations among RE, 
BMI, and CVD morbidity and mortality in both men and women in a large cohort study. 
Furthermore, intensity of AE and RE were not evaluated in this study. Therefore, more 
studies on the effects of different intensity of RE on cardiovascular health is clearly 
warranted. In addition, we assumed causal associations for this observational study. 
However, it is possible that healthier individuals were more likely to participate in RE who 
are less likely to develop CVD and die prematurely, which refers to a possible reverse 
causality. Therefore, further studies with objective measurement of RE and a large 
randomized clinical trials of RE training are clearly warranted to examine the causal effects 
of RE on the risk of developing CVD and mortality as well as to confirm the U-shaped dose-
response association between RE and CVD risk.
Conclusion
This study suggests that low-to-moderate frequency and amount of RE is associated with 
reduced risk of nonfatal CVD events, total CVD events, and all-cause mortality independent 
of AE, and high frequency and amount of RE did not show significant cardiovascular 
benefits. A mediation association exists among RE, BMI, and the risks of total CVD events, 
showing that RE has a direct U-shape association with the risk of total CVD events, and RE 
also decreases the risk of CVD events indirectly by lowering BMI. These results have 
potential public health applications, especially for the prevention of CVD, as RE is needed 
in addition to AE to maximize CVD prevention.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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FIGURE 1—. Path Diagram for Mediation Association among Resistance Exercise, Body Mass 
Index, and Total CVD Events.
This figure depicts result of a joint model with total CVD events as outcome. The solid 
arrows represent significant effect. The relationship curves and hazard ratios (coefficients) 
and 95% confidence intervals were positioned above or under the arrows.
Liu et al. Page 13













FIGURE 2—. The Dose-response Relationship between Resistance Exercise and Risk of Total 
CVD Events, CVD Morbidity, and All-Cause Mortality.
Dotted lines represent 95% confidence intervals for the hazard ratios. Quadratic trend p 
value is presented in each figure. Models were adjusted for baseline examination year, age 
(years), sex, baseline smoking status (current smoker or not), alcohol consumption (heavy 
drinker or not), parental history of cardiovascular disease (yes or no), body mass index 
(kg/m2), aerobic exercise (average physical activity ≥500 MET-minutes/week or not), 
hypertension (yes or no), diabetes (yes or no), and hypercholesterolemia (yes or no). Figure 
(a), (c) and (e) shows significant U-shape associations between weekly frequency of 
resistance exercise with three outcomes. The lowest risk of CVD and all-cause mortality is 
attained at resistance exercise of two times/week. Figure (b) shows significant quadratic 
association between weekly hours of resistance exercise with risk of total CVD events. 
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Figure (d) and (e) shows weekly hours of resistance exercise has no significant quadratic 
association with risk of CVD morbidity and all-cause mortality.
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TABLE 1.
Baseline Characteristics by Weekly Frequency of Resistance Exercise











Female 1,891 (20.7) 42 (16.3) 235 (26.1) 304 (19.8) 138 (18.5)
Age (year) 47.0 ± 9.7 44.0 ± 8.1 44.8 ± 8.5 45.7 ± 8.9 45.5 ± 10.3
Heavy alcohol drinker
a 1,082 (11.8) 32 (12.4) 117 (13.0) 176 (11.5) 91 (12.2)
Current smoker 1,101 (12) 28 (10.9) 91 (10.1) 139 (9.1) 83 (11.2)
Parental CVD 2,451 (26.8) 58 (22.5) 207 (22.9) 393 (25.6) 178 (23.9)
Meeting aerobic exercise guidelines
b 4,589 (50.1) 185 (71.7) 727 (80.6) 1,245 (81.2) 630 (84.7)
Body mass index (kg/m2)
c 26.3 ± 4.2 25.7 ± 3.4 25.2 ± 3.7 25.5 ± 3.6 25.2 ± 3.6
Hypertension
d 2,723 (29.7) 55 (21.3) 212 (23.5) 394 (25.7) 182 (24.5)
Diabetes
e 398 (4.3) 11 (4.2) 30 (3.3) 49 (3.2) 20 (2.7)
Hypercholesterolemia
f 2,986 (32.6) 65 (25.2) 245 (27.2) 399 (26.0) 156 (21.0)
Values are number (%) or mean ± SD.
a
Defined as alcohol drinks >14 and >7 per week for men and women, respectively.
b
Defined as aerobic exercise ≥500 MET-minutes per week.
c
Calculated as the weight in kilograms divided by the square of the height in meters.
d
Defined as systolic blood pressure ≥140 mmHg, diastolic blood pressure ≥90 mmHg, or previous diagnosis by a physician.
e
Defined as fasting glucose ≥126 mg/dl, previous diagnosis by a physician, or insulin use.
f
Defined as total cholesterol ≥240 mg/dl, or previous diagnosis by a physician.
CVD, cardiovascular disease; SD, standard deviation.













Liu et al. Page 17
TABLE 2.
Hazard Ratio (95% CI) of Total CVD Events, CVD Morbidity, and All-Cause Mortality by Resistance 
Exercise
Total CVD Events CVD Morbidity All-Cause Mortality
No. of 
Events / No. 
of 
Participants
HR (95% CI) No. of 
Events / No. 
of 
Participants
HR (95% CI) No. of 
















Weekly Frequency of Resistance Exercise (times/week)























































 p-value for Linear Trend:
0.15 0.73 0.50 0.84 0.46 0.96
 p-value for Quadratic Trend:
<0.001 <0.001 <0.001 <0.001 <0.001 <0.001
Weekly Minutes of Resistance Exercise (minutes/week)



















































 p-value for Linear Trend:
0.62 0.56 0.83 0.28 0.28 0.65
 p-value for Quadratic Trend:
0.002 0.02 0.049 0.21 0.48 0.75
a
Model 1 was adjusted for baseline examination year, age (years) and sex.
b
Model 2 was adjusted for Model 1 plus baseline smoking status (current smoker or not), alcohol consumption (heavy drinker or not),parental 
history of cardiovascular disease (yes or no), body mass index (kg/m2), aerobic exercise (average physical activity ≥500 MET- minutes/week or 
not), hypertension (yes or no), diabetes (yes or no), and hypercholesterolemia (yes or no).
CI, confidence interval; CVD, cardiovascular diseases; HR, hazard ratio.
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TABLE 3.
Regression Coefficients (95% CI) and Hazard Ratios (95% CI) of Total CVD Events, CVD Morbidity, and 
All-Cause Mortality by Resistance Exercise with BMI in Joint Model
































Cox Model (Total CVD Events, CVD Morbidity, and All-Cause Mortality as Outcome)
b
 Weekly Frequency of Resistance Exercise










































































































The first part of this table shows the result of joint model for weekly frequency of resistance exercise, and the second part shows result for weekly 
hours of resistance exercise.
a
The linear mixed effect model part was adjusted for follow-up years, examination year, baseline age (years), sex, current smoking (yes or no), 
heavy alcohol drinking (yes or no), and meeting the aerobic exercise guidelines (yes or no).
b
The Cox model part was adjusted for baseline examine year, age (years), sex, current smoking (yes or no), heavy alcohol drinking (yes or no), 
parental history of cardiovascular disease (yes or no), meeting the aerobic exercise guidelines (yes or no), hypertension (yes or no), diabetes (yes or 
no), and hypercholesterolemia (yes or no).
BMI, body mass index; CI, confidence interval; CVD, cardiovascular diseases; HR, hazard ratio.
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